Being Overweight May Raise Cancer Risk

Researchers from the University of Manchester, Christie Hospital and University of Bern in Switzerland have today published findings in the Lancet medical journal which further support the link between obesity and risk of developing cancer.

Following on from findings reported by the World Cancer Research fund last year, the study reveals that risk is increased not only in common cancers such as breast, bowel and kidney, but also in less common cancers such as blood cancers (myeloma and leukaemia) and melanoma (a form of skin cancer).

Dr Andrew Renehan and colleagues from the University of Manchester and Christie Hospital, did a meta-analysis (a combined analysis of 221 previous studies), looking at over 250,000 cases of cancer, to determine the risk of cancer associated with a 5kg/m² increase in body mass index (BMI).

The researchers found in men, a 5kg/m² increase in BMI raised the risk of oesophageal adenocarcinoma by 52%, thyroid cancer by 33%, and colon and kidney cancers each by 24%.

In women, a BMI increase of 5kg/m² increased the risk of endometrial (59%), gallbladder (59%), oesophageal adenocarcinoma (51%) and kidney (34%) cancers.

They also noted weaker, but significant, positive associations between increased BMI and rectal cancer and malignant melanoma in men; postmenopausal breast, pancreatic, thyroid, and colon cancers in women; and leukaemia, multiple myeloma, and non-Hodgkin's lymphoma in both sexes. They found associations were stronger in men than in women for colon cancer - 24% in men compared with 9% in women.

The study looked at cancer data from all over the world, and while the results for North America, Europe, Australia and the Asia-Pacific region were broadly similar, there was a stronger link between increased BMI and both premenopausal and post menopausal breast cancers in Asia-Pacific populations.

The senior author on the study, Dr Andrew Renehan, said: "This was a hugely comprehensive piece of research looking at 221 different studies in 20 types of cancer. For some cancer types, associations differ between sexes and populations of different ethnic origins and this should inform the exploration of biological mechanisms that link obesity with cancer."

He added: "Over the past five years, there was been increasing proof that obesity is linked with cancer risk, but despite this, we do not know whether weight reduction in people protects them against cancer. The findings of this study are important to address these issues and explore ways to prevent cancers in the future."

In an accompanying comment, Dr Susanna Larsson and Dr Alicja Wolk, Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, say: "The number of deaths per year attributable to obesity is about 30000 in the UK and ten times that in the USA, where obesity has been estimated to have overtaken smoking in 2005 as the main preventable cause of illness and premature death."

They conclude: "Efforts will be needed to increase education on diet and physical activity, train health professionals, restrict advertisements of high-calorie and low-nutrient foods, limit access to unhealthy foods in schools and workplaces, levy taxes on sugary drinks and other foods high in calories, fat, or sugar, lower the prices of health foods, and promote physical activity in schools and workplaces. National cancer plans should include all these factors to reduce obesity, and thus decrease cancer incidence and increase survival."

Source: University of Manchester

Related stories:

H. Pylori bacteria may help prevent some esophageal cancers
Some bacteria may help protect against the development of a type of esophageal cancer, known as adenocarcinoma, according to a new review of the medical literature. These bacteria, which are called Helicobacter pylori, live in the stomachs of humans.
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
Low cholesterol associated with cancer in diabetics
Low levels of LDL cholesterol as well as high levels are associated with cancer in patients with type 2 diabetes, found a prospective cohort study published in CMAJ.
PSA screening may be biased against obese men, leading to more aggressive cancers
Testing men for elevated levels of prostate-specific antigen (PSA) in the blood -- the gold standard screening test for prostate cancer -- may be biased against obese men, whose PSA levels tend to be deceptively low. And this bias may be creating more aggressive cancers in this population by delaying diagnosis, according to a new study led by investigators in the Duke Prostate Center and the Durham Veterans Affairs (VA) Medical Center.
Overweight, insulin resistant women at greater risk of advanced breast cancer diagnosis, says study
Women who have risk factors commonly associated with Type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer, according to research to be presented today.
Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction. However, the research reveals that variations between countries in policies for mass screening, access to health care and treatment are reflected in the different cancer rates.
Get a Little Sun This Summer – It Could Help Save Your Life
As summer comes and people across America get ready to start slathering on the sunscreen, a note of caution is in order – a little sunshine is good for you.
Calorie restriction limits and obesity fuels development of epithelial cancers
A restricted-calorie diet inhibited the development of precancerous growths in a two-step model of skin cancer, reducing the activation of two signaling pathways known to contribute to cancer growth and development, researchers at The University of Texas M. D. Anderson Cancer Center report today at the American Association for Cancer Research annual meeting.

News discussion:

Medicine & Health news